Details of the Probe-central Interaction Altas
General Information of Experiment
Probe Name | DFG-out-3 | Probe Info | ||||
---|---|---|---|---|---|---|
Probe concentration | 1 uM | |||||
Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
Quantitative Method |
SILAC
|
|||||
Competitor Name | Ranjitkar_cp1 | Competitor Info | ||||
Competitor Concentration | 10 uM | |||||
In Vivo Experiment Model | Model Type |
|
Cell lysate | |||
Derived Tissue |
|
Skin | ||||
Disease Model | Skin squamous cell carcinoma [ICD-11:2C31] | |||||
Model Name | Human skin squamous cell carcinoma cell lysate (A431) | |||||
Interaction Altas of This Experiment [1]
Enzyme
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP03992 | Tyrosine-protein kinase FRK (FRK) | 100.0 | ||||
LDTP04631 | Ephrin type-B receptor 4 (EPHB4) | 35.0 | ||||
LDTP03445 | Mitogen-activated protein kinase 1 (MAPK1) | 19.0 | ||||
LDTP03474 | Ephrin type-A receptor 2 (EPHA2) | 15.0 | ||||
LDTP03477 | Ephrin type-B receptor 2 (EPHB2) | 15.0 | ||||
LDTP02638 | Proto-oncogene tyrosine-protein kinase Src (SRC) | 14.0 | ||||
LDTP00907 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (PDE6D) | 10.5 | ||||
LDTP03008 | Spermidine synthase (SRM) | 9.9 | ||||
LDTP05996 | Protein-tyrosine kinase 6 (PTK6) | 7.7 | ||||
LDTP13056 | Leucine--tRNA ligase, cytoplasmic (LARS1) | 4.3 | ||||
LDTP12148 | UDP-glucuronosyltransferase 1A10 (UGT1A10) | 4.0 | ||||
LDTP09355 | Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (PIP4K2C) | 3.9 | ||||
LDTP04319 | Glycogen synthase kinase-3 beta (GSK3B) | 3.6 | ||||
LDTP06100 | Protein-tyrosine kinase 2-beta (PTK2B) | 2.7 | ||||
LDTP01420 | Serine/threonine-protein kinase 10 (STK10) | 2.7 | ||||
LDTP05453 | Focal adhesion kinase 1 (PTK2) | 2.5 | ||||
LDTP04584 | Mitogen-activated protein kinase 10 (MAPK10) | 2.5 | ||||
LDTP06455 | Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (NSDHL) | 2.4 | ||||
LDTP02149 | Cyclin-dependent kinase 1 (CDK1) | 2.1 | ||||
LDTP03692 | Bifunctional epoxide hydrolase 2 (EPHX2) | 2.0 | ||||
LDTP07975 | Serine/threonine-protein kinase TAO1 (TAOK1) | 2.0 | ||||
LDTP03944 | Tyrosine-protein kinase CSK (CSK) | 2.0 |
Transporter and channel
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP12533 | Ubiquilin-4 (UBQLN4) | 2.1 |
Other
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP13110 | Coatomer subunit gamma-2 (COPG2) | 7.9 | ||||
LDTP11212 | Tubulin-specific chaperone D (TBCD) | 4.9 | ||||
LDTP03557 | Leukocyte elastase inhibitor (SERPINB1) | 2.5 | ||||
LDTP16716 | Putative peripheral benzodiazepine receptor-related protein (TSPO) | 2.1 |